-+ 0.00%
-+ 0.00%
-+ 0.00%

REGENERON PHARMACEUTICALS - APPROVAL INTRODUCES LIBTAYO 700 MG EVERY SIX WEEKS AFTER INITIAL 12 WEEKS OF 350 MG EVERY 3 WEEKS

Reuters·11/17/2026 12:00:08

Please log in to view news